2-chloro-n(6)cyclopentyladenosine has been researched along with pyrilamine in 1 studies
| Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (pyrilamine) | Trials (pyrilamine) | Recent Studies (post-2010) (pyrilamine) |
|---|---|---|---|---|---|
| 252 | 0 | 43 | 1,860 | 26 | 116 |
| Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | pyrilamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.13 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.976 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.3 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.997 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.13 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.0015 | |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | 0.0126 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.047 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0166 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.788 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.879 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.1 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Zeeuw, S; Duncker, DJ; Liem, DA; van den Doel, MA; Verdouw, PD | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and pyrilamine
| Article | Year |
|---|---|
Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors.
Topics: Acetamides; Adenosine; Analysis of Variance; Animals; Cryoprotective Agents; Dihydropyridines; Histamine H1 Antagonists; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Pyrilamine; Rats; Rats, Wistar; Receptors, Purinergic; Receptors, Purinergic P1; Theophylline; Time Factors | 2001 |